NLRP3-IN-33
NLRP3-IN-33 (Compound 12o) is a blood-brain barrier permeable inhibitor of AChE and BChE, with IC50 values of 1.02 μM and 7.03 μM against hAChE and hBChE respectively. NLRP3-IN-33 possesses antioxidant, anti-inflammatory, and metal chelating activities, making it a potential candidate for research in Alzheimer's disease (AD) [1].
Product Specifications
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nlrp3-in-33.html
Solubility
10 mM in DMSO
Smiles
O=C(NCC(NC1=C2C=CC=NC2=C(O)C=C1)=O)/C=C/C3=CC=C(O)C(OC)=C3
Molecular Formula
C21H19N3O5
Molecular Weight
393.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
Ephrin B3 (EFNB3, Ephrin B3 (EFL6, EPH-related receptor transmembrane ligand ELK-L3, EPH-related receptor tyrosine kinase ligand 8, Ephrin-B3, EPLG8, LERK8) discontinued
